Kiniksa Pharmaceuticals (NASDAQ:KNSA) Sets New 1-Year High at $20.94

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $20.94 and last traded at $20.83, with a volume of 197612 shares traded. The stock had previously closed at $20.16. Analyst Ratings Changes KNSA has been the topic of […]

Related Keywords

Canada ,Michaelr Megna ,Johnf Paolini , ,Advisors Inc ,Kiniksa Pharmaceuticals ,Securities Exchange Commission ,Nasdaq ,Kiniksa Pharmaceuticals Stock Performance ,Royal Bank ,Kiniksa Pharmaceuticals Ltd ,Lazard Asset Management ,Altshuler Shaham Ltd ,News Ratings For Kiniksa Pharmaceuticals Daily ,Tower Research Capital ,Get Free Report ,Exchange Commission ,Research Capital ,Asset Management ,Shaham Ltd ,Kiniksa Pharmaceuticals Daily ,